Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.49 USD | -0.57% | +2.16% | +13.52% |
Apr. 29 | Colgate-Palmolive's Strong Q1 Results Support Outperformance, Morgan Stanley Says | MT |
Apr. 29 | Stifel Nicolaus Adjusts Colgate-Palmolive Price Target to $95 From $94, Maintains Buy Rating | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- With a 2024 P/E ratio at 26.07 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- With an enterprise value anticipated at 4.06 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.52% | 74.67B | A+ | ||
+10.32% | 381B | C- | ||
+8.03% | 129B | B- | ||
-16.39% | 62.59B | A- | ||
+0.37% | 52.86B | B+ | ||
-11.47% | 36.11B | - | ||
+2.76% | 33.57B | B- | ||
+9.68% | 17.29B | A- | ||
+7.68% | 14.75B | B | ||
-9.06% | 10.82B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CL Stock
- Ratings Colgate-Palmolive Company